2-[(2,6,8-Trisubstituted-4-(3H)-oxoqunazolin-3-yl) amino]-5-aryl/heteryl-1,
3,4-thiadiazoles (4-12) on reaction with nicotinoyl chloride afforded title
compounds viz. 3-{[N-(2,6,8-trisubstituted-4(3H)-oxoquinazolin-3-yl) -N-ni
cotinyl] amino}-5-aryl/hereryl-1,3,4-thiadiazoles (13-21) in quantitative y
ields. Nine such title compounds were evaluated for antiinflammatory activi
ty by standard In-vivo and In-vitro models. They exhibited significant prot
ection against carrageenan induced rat paw edema.